Lomustine USP/EP – Anti-Neoplastic (Anti-Cancer) API
Lomustine USP/EP is a high-quality anti-neoplastic active pharmaceutical ingredient (API) belonging to the nitrosourea class of alkylating agents. It is widely used in the pharmaceutical industry for the formulation of medicines intended to treat various types of cancer, particularly tumors affecting the central nervous system. Due to its lipophilic nature, Lomustine readily crosses the blood-brain barrier, making it one of the most effective APIs for the treatment of primary and metastatic brain tumors. It is also used as part of combination chemotherapy regimens for Hodgkin lymphoma and certain other malignancies where alkylating agents play a vital therapeutic role.
Lomustine works by damaging the DNA of rapidly dividing cancer cells through alkylation and cross-linking, thereby inhibiting DNA replication and RNA synthesis. This disruption prevents cancer cells from multiplying and ultimately leads to programmed cell death (apoptosis). Because of its unique pharmacological properties, Lomustine has remained an important component of oncology treatment protocols for several decades and continues to be recommended in specific cancer management guidelines.
Manufactured in accordance with USP/EP quality standards, our Lomustine API is produced under stringent quality control systems to ensure high purity, consistency, and compliance with international pharmaceutical requirements. Each batch undergoes rigorous analytical testing to meet defined specifications for identity, assay, impurities, and overall quality, making it suitable for pharmaceutical formulation and regulated markets.
Lomustine is commonly utilized by pharmaceutical manufacturers developing oral chemotherapy formulations and oncology products. The API is handled under carefully controlled manufacturing conditions to maintain its stability and effectiveness throughout production and storage. Proper packaging and storage protect the material from moisture, heat, and light, ensuring product integrity until formulation.
As a trusted pharmaceutical API supplier, we are committed to delivering reliable oncology ingredients that meet global quality expectations. Our Lomustine USP/EP API is supported by comprehensive quality documentation, enabling pharmaceutical companies to develop safe, effective, and regulatory-compliant anti-cancer medications for patients worldwide.
